Correction: Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/5/e004699corr1.full |